Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 10 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             45.66               29.55            65.00    
                 (+54.5 pct)         (+20.3 pct)      (+41.0 pct) 
  Operating         19.93                8.79            26.00    
                (+126.7 pct)        (+126.6 pct)      (+86.3 pct) 
  Recurring         20.15                8.92            26.20    
                (+126.0 pct)        (+128.9 pct)      (+85.0 pct) 
  Net               14.36                5.73            18.50    
                (+150.8 pct)        (+111.4 pct)      (+93.8 pct) 
  EPS            119.29 yen           47.56 yen       153.63 yen  
  Ann Div                             16.00 yen        30.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             16.00 yen        30.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news